RDP Law Group represents victims across the nation who have suffered from complications related to Xeljanz or Xeljanz XR. If you or a loved one has been injured, you may be entitled to compensation from the drug manufacturer.
*** The information on this page is intended for educational purposes only. ***
Many patients suffering from rheumatoid arthritis, paoratic arthritis or ulcerative colitis take Xeljanz or Xeljanz XR as treatment for their condition. A recent medical study revealed serious and potentially fatal risks for some patients related to Xeljanz and Xeljanz XR.
On February 26, 2019, the U.S. Food and Drug Administration (FDA) issued a consumer alert stating that post market clinical trials found an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of Xeljanz | XR was used in patients with rheumatoid arthritis. In response, the FDA required drug manufacturer Pfizer to add new language to a black box warning on the drug label of Xeljanz and Xeljanz XR.
Black box warnings are only required when a drug has the potential to cause serious injuries or death and should be taken seriously by doctors and patients.
The FDA recommends patients who are at high risk for thrombosis (blood clots) should not take Xeljanz or Xeljanz XR due to the high risk of death or serious injury. In all patients, the FDA suggests that the medication be taken in the smallest possible dose for the shortest amount of time for effective treatment. Blood clots can impair or block the flow of blood to certain parts of the body resulting in serious injuries. Blood clots that form in or travel to the heart, brain or lungs can cause death.
If you or a loved one are taking Xeljanz or Xeljanz XR and begin experiencing any of the above symptoms you should seek immediate medical attention.
Lawsuits have been filed against Pfizer, the manufacturer of Xeljanz and Xeljanz XR, claiming the company failed to warn consumers about the risks associated with the medication.
There is ongoing litigation against the makers of Xeljanz and Xeljanz XR and it’s not too late for you to join. RDP Law Group can help you recover compensation for your injuries. Complete the form below and someone from our team will contact you right away for a free case evaluation.
When doctors prescribe medicine, they rely on safety disclosures made by the pharmaceutical companies, like Pfizer, which produce prescription drugs. If risks are not adequately disclosed, doctors are left with an incomplete understanding of the risks and potential side effects that drugs like Xeljanz can cause for patients. Failure to warn creates a very dangerous and potentially deadly situation for some patients. Consumers and pharmacists also rely on adequate disclosures to help them make informed decisions about their health and medical treatment.
Litigation against Pfizer claims that Xeljanz’s warning label and marketing material downplayed the risks of certain side effects. Plaintiffs are seeking compensation from Pfizer and want to hold the company accountable for the damage caused by this dangerous drug.
